Deka Bank Deutsche Girozentrale Amgen Inc Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Amgen Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 711,647 shares of AMGN stock, worth $195 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

711,647

Previous 703,638 1.14%

Holding current value

$195 Million

Previous $221 Million 4.59%

% of portfolio

0.43%

Previous 0.4%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $2.48 Million - $2.7 Million	8,009 Added 1.14%	711,647 $231 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $16.9 Million - $20.5 Million	-64,305 Reduced 8.37%	703,638 $221 Million
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $3.91 Million - $4.72 Million	14,557 Added 1.93%	767,943 $219 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $13.9 Million - $15.7 Million	-54,318 Reduced 6.72%	753,386 $216 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $77.9 Million - $96.8 Million	-356,430 Reduced 30.62%	807,704 $218 Million
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $45.4 Million - $53.7 Million	212,080 Added 22.28%	1,164,134 $259 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $72,930 - $88,889	323 Added 0.03%	952,054 $230 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $5.28 Million - $6.71 Million	-23,072 Reduced 2.37%	951,731 $249 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $16.6 Million - $18.7 Million	73,784 Added 8.19%	974,803 $222 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $45.3 Million - $50.4 Million	-196,282 Reduced 17.89%	901,019 $221 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $41.7 Million - $46.1 Million	190,201 Added 20.97%	1,097,301 $267 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $8.39 Million - $9.61 Million	42,205 Added 4.88%	907,100 $208 Million
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $22.5 Million - $26.3 Million	105,895 Added 13.95%	864,895 $186 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $7.14 Million - $7.92 Million	-30,568 Reduced 3.87%	759,000 $183 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $61.1 Million - $71.2 Million	-275,182 Reduced 25.84%	789,568 $197 Million
Q4 2020 Mar 12, 2021	BUY	$216.38 - $257.67 $18.5 Million - $22.1 Million	85,595 Added 8.74%	1,064,750 $243 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $93.3 Million - $104 Million	397,749 Added 68.41%	979,155 $244 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $2.39 Million - $2.93 Million	-12,087 Reduced 2.04%	581,406 $135 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $28.5 Million - $37.8 Million	-156,516 Reduced 20.87%	593,493 $125 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $55.8 Million - $71.7 Million	-294,991 Reduced 28.23%	750,009 $181 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $18.9 Million - $22.6 Million	-108,511 Reduced 9.41%	1,045,000 $204 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $48.8 Million - $57.2 Million	292,548 Added 33.98%	1,153,511 $213 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $285,231 - $321,518	-1,577 Reduced 0.18%	860,963 $173 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $281,336 - $328,410	1,577 Added 0.18%	862,540 $165 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $20.7 Million - $23.3 Million	111,610 Added 14.89%	860,963 $0
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $12.7 Million - $14.2 Million	-76,351 Reduced 9.25%	749,353 $138 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $10.6 Million - $12.4 Million	-62,440 Reduced 7.03%	825,704 $141 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $149 Million - $170 Million	888,144	888,144 $152 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Amgen Inc Transaction History